Health Sciences Authority (HSA) is Singapore’s national authority regulating health products, including medications. Every month, HSA publishes a list of medications that are newly approved or medications with newly approved indication(s). This list can be found on HSA’s website.
August 2021
- New drugs approved: 1
- New drug indications approved: 1
New drugs approved
| Product name | Active ingredient(s) | Dosage Form | Strength of dosage form | Route of Administration | Indication(s) | Pharmaceutical company | Approval Date |
| Leqvio | Inclisiran | Pre-Filled Syringe/Pen | 284mg/1.5mL | Injection | Treatment in adults with primary hypercholesterolaemia, as an adjunct to diet | Novartis | 03 Aug 2021 |
New drug indications approved
| Product name | Active ingredient(s) | Dosage Form | Strength of dosage form | Route of Administration | Indication(s) | Pharmaceutical company | Approval Date |
| Lipiodol Ultra-Fluide | Ethyl Esters of Iodised Fatty Acids of Poppy-Seed Oil | Ampoule | 38% w/w | Injection | Visualisation, locating and vectoring during transarterial chemoembolisation of intermediate-stage hepatocellular carcinoma in adults. | Angeion Medical International | 26 Aug 2021 |
